GlycoMark® Testing for Glycemic Control
J15 · Effective Mar 6, 2017
23 active Medicare policies list 84999, and 36 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15 · Effective Mar 6, 2017
JE · Effective Aug 1, 2017
JF · Effective Aug 1, 2017
JJ · Effective Oct 17, 2016
JM · Effective Oct 17, 2016
J6 · Effective Oct 1, 2015
JK · Effective Oct 1, 2015
JE · Effective Oct 1, 2018
JF · Effective Oct 1, 2018
36 policies from 8 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 84999 |
|---|---|---|
| Analysis of Proteomic and Metabolomic Patterns for Cancer Detection, Risk, Prognosis, or Treatment Selection | Mar 1, 2026 | Covered |
| Bone Turnover Markers for Diagnosis and Management of Osteoporosis and Diseases Associated with High Bone Turnover | Oct 1, 2025 | Covered |
| Gene Expression-Based Assays for Cancers of Unknown Primary | Jun 1, 2026 | Covered |
| In Vitro Chemoresistance and Chemosensitivity Assays | Apr 1, 2026 | Covered |
| Molecular Testing in the Management of Pulmonary Nodules | Dec 1, 2025 | Covered |
| Multi-biomarker Disease Activity Blood Test for Rheumatoid Arthritis |
JJ · Effective Oct 1, 2015
JM · Effective Oct 1, 2015
JE · Effective Jul 21, 2017
JF · Effective Jul 21, 2017
National · Effective Oct 16, 2025
National · Effective Apr 2, 2026
National · Effective Jul 27, 2023
J6 · Effective Apr 1, 2026
National · Effective Oct 16, 2025
National · Effective Jan 1, 2025
National · Effective Oct 16, 2025
| Sep 1, 2025 |
| Covered |
| Multianalyte and Gene Expression Assays for Predicting Recurrence in Colon Cancer | Dec 1, 2025 | Covered |
|---|
| Salivary Hormone Testing for Aging and Menopause | May 1, 2026 | Covered |
|---|
| Serum Holotranscobalamin as a Marker of Vitamin B12 (i.e., Cobalamin) Status | Apr 1, 2026 | Covered |
|---|
| Targeted Genetic Testing for Selection of Therapy for Non-Small Cell Lung Cancer (NSCLC) | Mar 1, 2026 | Covered |
|---|
| Policy | Effective | Status of 84999 |
|---|---|---|
| Algorithmic Tests for Liver Fibrosis | Oct 1, 2026 | Not covered |
| Blood-based Biomarker Tests for Multiple Sclerosis | Oct 1, 2026 | Not covered |
| Laboratory Evaluation of Vitamin B12 | Jan 6, 2026 | Covered |
| Per- and Polyfluoroalkyl Substances (PFAS) Testing | Oct 1, 2026 | Not covered |
| Saliva-based Testing to Determine Drug-Metabolizer Status | Apr 15, 2026 | Not covered |
| Selected Protein Biomarker Algorithmic Assays | Oct 1, 2026 | Not covered |
| Testing for Biochemical Markers for Alzheimer Disease | Jul 1, 2026 | Covered |
| Topographic Genotyping | Apr 15, 2026 | Not covered |
| Policy | Effective | Status of 84999 |
|---|---|---|
| Drug Testing in Pain Management and Substance Use Disorder Treatment | Jan 1, 2026 | Covered |
| Intracellular Micronutrient Analysis | Apr 1, 2026 | Covered |
| Measurement of Serum Antibodies to Selected Biologic Agents | Jan 1, 2026 | Covered |
| Tests for Amniotic Protein to Detect Rupture of Membranes (ROM) in Pregnancy | Jun 15, 2026 | Covered |
| Policy | Effective | Status of 84999 |
|---|---|---|
| Drug Testing in Pain Management and Substance Use Disorder Treatment | Jan 1, 2026 | Covered |
| Intracellular Micronutrient Analysis | Apr 1, 2026 | Covered |
| Measurement of Serum Antibodies to Selected Biologic Agents | Jan 1, 2026 | Covered |
| Tests for Amniotic Protein to Detect Rupture of Membranes (ROM) in Pregnancy | Jun 15, 2026 | Covered |
| Policy | Effective | Status of 84999 |
|---|---|---|
| Drug Testing in Pain Management and Substance Use Disorder Treatment | Jan 1, 2026 | Covered |
| Intracellular Micronutrient Analysis | Apr 1, 2026 | Covered |
| Measurement of Serum Antibodies to Selected Biologic Agents | Jan 1, 2026 | Covered |
| Tests for Amniotic Protein to Detect Rupture of Membranes (ROM) in Pregnancy | Jun 15, 2026 | Covered |
| Policy | Effective | Status of 84999 |
|---|---|---|
| Drug Testing in Pain Management and Substance Use Disorder Treatment | Jan 1, 2026 | Covered |
| Intracellular Micronutrient Analysis | Apr 1, 2026 | Covered |
| Measurement of Serum Antibodies to Selected Biologic Agents | Jan 1, 2026 | Covered |
| Tests for Amniotic Protein to Detect Rupture of Membranes (ROM) in Pregnancy | Jun 15, 2026 | Covered |
| Policy | Effective | Status of 84999 |
|---|---|---|
| Complementary and Alternative Medicine | Feb 15, 2026 | Not covered |
| Policy | Effective | Status of 84999 |
|---|---|---|
| Molecular Pathology/Genetic Testing Reported with Unlisted Codes | Not recorded | Covered |